Cargando…
P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430939/ http://dx.doi.org/10.1097/01.HS9.0000970476.94163.1b |
| _version_ | 1785091079967604736 |
|---|---|
| author | Oriol, Albert Qi, Keqin Londhe, Anil Nair, Sandhya Lin, Xiwu Pei, Lixia Ammann, Eric Heuck, Christoph Renaud, Thomas Kane, Colleen Parekh, Trilok Peterson, Steve |
| author_facet | Oriol, Albert Qi, Keqin Londhe, Anil Nair, Sandhya Lin, Xiwu Pei, Lixia Ammann, Eric Heuck, Christoph Renaud, Thomas Kane, Colleen Parekh, Trilok Peterson, Steve |
| author_sort | Oriol, Albert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430939 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309392023-08-17 P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS Oriol, Albert Qi, Keqin Londhe, Anil Nair, Sandhya Lin, Xiwu Pei, Lixia Ammann, Eric Heuck, Christoph Renaud, Thomas Kane, Colleen Parekh, Trilok Peterson, Steve Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430939/ http://dx.doi.org/10.1097/01.HS9.0000970476.94163.1b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Oriol, Albert Qi, Keqin Londhe, Anil Nair, Sandhya Lin, Xiwu Pei, Lixia Ammann, Eric Heuck, Christoph Renaud, Thomas Kane, Colleen Parekh, Trilok Peterson, Steve P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS |
| title | P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS |
| title_full | P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS |
| title_fullStr | P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS |
| title_full_unstemmed | P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS |
| title_short | P893: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS PHYSICIAN’S CHOICE THERAPY IN TRIPLE-CLASS EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHED COHORT ANALYSIS |
| title_sort | p893: comparative effectiveness of talquetamab vs physician’s choice therapy in triple-class exposed patients with relapsed/refractory multiple myeloma: a matched cohort analysis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430939/ http://dx.doi.org/10.1097/01.HS9.0000970476.94163.1b |
| work_keys_str_mv | AT oriolalbert p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT qikeqin p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT londheanil p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT nairsandhya p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT linxiwu p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT peilixia p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT ammanneric p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT heuckchristoph p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT renaudthomas p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT kanecolleen p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT parekhtrilok p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis AT petersonsteve p893comparativeeffectivenessoftalquetamabvsphysicianschoicetherapyintripleclassexposedpatientswithrelapsedrefractorymultiplemyelomaamatchedcohortanalysis |